This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Rheinische Friedrich-Wilhelms-Universitat Bonn. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations of Markus Hafner in Pharmaceutical Composition
Introduction
Markus Hafner is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating autoimmune and tumoral diseases.
Latest Patents
Hafner holds a patent for "Low-molecular inhibitors of cytohesin-family guanine nucleotide exchange factors." This invention relates to a pharmaceutical composition that includes compounds selected from specific general formulas and their enantiomers, diastereomers, or pharmaceutically acceptable salts. The composition is designed for use in treating autoimmune and tumoral diseases, as well as for immunosuppression.
Career Highlights
Markus Hafner is affiliated with the Rheinische Friedrich-Wilhelms-Universität Bonn, where he has been involved in research and development in the pharmaceutical sector. His work has been instrumental in advancing therapeutic options for patients suffering from complex diseases.
Collaborations
Hafner has collaborated with esteemed colleagues such as Michael Famulok and Imke Grune, contributing to a rich environment of innovation and research.
Conclusion
Markus Hafner's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His patent reflects a commitment to addressing critical health challenges through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile